The bubble is arguing: the precision medical plan has the suspicion of following the trend
Most of the precision medical industries with more than 100 million yuan of financing are sequencing companies, lacking core technologies and good business models, and some even do not understand the nature of tumor genome data. The 53-year-old Cui Zhiqing (a pseudonym) has had a serious decline in memory for more than half a year, and sometimes he has forgotten everything he has done the day before. Cui Zhiqing always thought that it might be old age, his brain is not working, and he didn’t take it seriously. One morning, Cui Zhiqing woke up from a severe headache before deciding to go to the hospital. Doctors from Peking Union Medical College Hospital found that Cui Zhiqing had a punctate calcification in the brain, and histopathology showed a grade III glioma. In order to accurately determine the glioma subtype, Union Hospital cooperated with a genetic company to conduct molecular pathological examination for Cui Zhiqing, and customized treatment plans based on the test. Today, his condition is in a stable state. Cui Zhiqing is the beneficiary of precision medicine . Precision medicine is a treatment that is tailored to the individual characteristics of each patient. The US Precision Medical Cluster project document defines “precise medical care†as an emerging approach to disease prevention and treatment that takes into account variables such as resident genes, environment, and lifestyle. In January 2015, US President Barack Obama announced the implementation of the “Precision Medical Plan†in the United States; two months later, the Chinese version of the “Precision Medical Plan†was introduced, with a planned investment of 60 billion yuan; the “13th Five-Year Plan†issued in early 2016, Accurate medical care has been included; up to now, the major projects of precision medicine have been successfully established, and more than 60 scientific research projects have been launched. The positive attitude of the Chinese and US governments has prompted a large number of enterprises and investments to enter this field. However, in recent days, precision medicine has been questioned by two academic papers published in the internationally authoritative academic journals Nature and New England Medicine: “Precision strategies have not brought benefits to most cancer patientsâ€, “In cancer Precision medicine is just an imaginary or hypothesis for precision treatment." There are also experts in China who criticize the "precise medical plan" for following the trend. These bad news is undoubtedly a good thing for patients who are hoping for accurate cancer treatment. Zhoushan City Shuangying Aquatic Products Co., Ltd.  , https://www.shuangying-aquatic.com